Advanced Biomed Inc Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Advanced Biomed Inc (ADVB) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of -$0.24 per share for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-05-15
- Advanced Biomed Inc income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-12-31 was -$0.01.
- Advanced Biomed Inc income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-03-31 was -$0.18.
- Advanced Biomed Inc income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-12-31 was -$0.02.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month |
|---|---|---|---|
| 2026-03-31 | -$0.24 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | -$0.01 10-Q · filed 2026-02-13 | -$0.01 10-Q · filed 2026-02-13 | |
| 2025-03-31 | -$0.18 10-Q · filed 2026-05-15 | -$0.79 10-Q · filed 2026-05-15 | |
| 2024-12-31 | -$0.02 10-Q · filed 2026-02-13 | -$0.03 10-Q · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |